Lombard Medical Technologies (LSE:LMT) 5-Year EBITDA Growth Rate : -48.90% (As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies 5-Year EBITDA Growth Rate?

Lombard Medical Technologies's EBITDA per Share for the six months ended in Dec. 2012 was £-0.40.

During the past 3 years, the average EBITDA Per Share Growth Rate was -24.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -48.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -50.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Lombard Medical Technologies was 7.00% per year. The lowest was -72.10% per year. And the median was -51.30% per year.

Competitive Comparison of Lombard Medical Technologies's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lombard Medical Technologies's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's 5-Year EBITDA Growth Rate falls into.

Lombard Medical Technologies 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Lombard Medical Technologies (LSE:LMT) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Lombard Medical Technologies 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.